Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-24-000523
Filing Date
2024-10-28
Accepted
2024-10-28 16:05:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2975
  Complete submission text file 0001973141-24-000523.txt   4461
Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Wallace Owen B. (Reporting) CIK: 0001778843 (see all company filings)

Type: 144

Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Subject) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40522 | Film No.: 241400880
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)